Table 1.
Selected PI3K inhibitors in clinical trials
View large
Selected PI3K inhibitors in clinical trials

CLL indicates chronic lymphocytic leukemia; NHL, non-HL; PTCL, peripheral T-cell lymphoma; and MM, multiple myeloma.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal